Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Sep;30(5):468-76.
doi: 10.1016/j.semnephrol.2010.07.004.

Fine tuning gene expression: the epigenome

Affiliations
Review

Fine tuning gene expression: the epigenome

Davoud Mohtat et al. Semin Nephrol. 2010 Sep.

Erratum in

  • Semin Nephrol. 2011 Jan;31(1):123

Abstract

An epigenetic trait is a stably inherited phenotype resulting from changes in a chromosome without alterations in the DNA sequence. Epigenetic modifications such as DNA methylation, together with covalent modification of histones, are thought to alter chromatin density and accessibility of the DNA to cellular machinery, thereby modulating the transcriptional potential of the underlying DNA sequence. As environmental changes influence epigenetic marks, epigenetics provides an added layer of variation that might mediate the relationship between genotype and internal and external environmental factors. Integration of our knowledge in genetics, epigenomics, and genomics with the use of systems biology tools may present investigators with new, powerful tools to study many complex human diseases such as kidney disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1. The effect of different external signals depends on epigenetic modification in the target cells
The cellular response to external signals may reflect chromatin-based (epigenetic) differences superimposed on the static genetic code. In this example, the 5-regulatory region of a disease susceptibility gene is depicted in cells. While in some cells the promoter assumes an “open” chromatin architecture characterized by activating histone posttranslational marks, decreased nucleosome density, and the lack of DNA methylation. RNA polymerase II is recruited to the promoter, resulting in productive transcription. Alternatively, in other cells the genetically identical promoter assumes a “closed” chromatin configuration characterized by repressive posttranslational marks, increased nucleosome density, and prominent DNA methylation. RNA polymerase II is not recruited to the promoter, and no transcription occurs. Transcriptionally Competenent Euchromatin is usually associated with umethylated DNA, and trimethyl H3K9 and H3K23 marks. Transcriptionally Incompetent Heterochromatin is generally associated with methylated DNA and trimethyl H3K4 and H3K6 marks.
Figure 2
Figure 2. The complex Interaction between Genotype and Phenotype Development
During normal development somatic cells that descended from a single progenitor, and contain similar genotype, differentiate to acquire diverse biological function by expressing and repressing different set of genes via establishing new epigenetic marks. While the genotype of an individual does not change hyperglycemia, uremia, different dietary and environmental factors might change the epigenome of cells leading to differences in gene and protein expression. Differences in the epigenotype might be response for the different (including disease) phenotype development. While the genotype is stable there is a more dynamic link between environmental factors and phenotype development.

References

    1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. - PubMed
    1. Takahashi K, Tanabe K, Ohnuki M, Narita M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872. - PubMed
    1. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313–317. - PubMed
    1. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer. 2004;4:143–153. - PubMed
    1. Dressler GR. Epigenetics, development, and the kidney. J Am Soc Nephrol. 2008;19:2060–2067. - PubMed

Publication types

LinkOut - more resources